Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Lymphom 30 oktober Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Lymphom Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Lymphoma, Follicular;Lymphoma, Large B-Cell, Diffuse, Date of authorisation: 23/08/2018, Revision: 12, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.